Patient Reported Outcomes and Early Toxicity from a Phase III Randomized Trial of Moderate vs. Ultrahypofractionated Radiation Therapy for Localized Prostate Cancer

被引：0
|
作者：
Farnia, Benjamin [1 ]
Dal Pra, Alan [2 ]
Kwon, Deukwoo [1 ]
Punnen, Sanoj [1 ]
Ricardi, Umberto [3 ]
Levis, Mario [3 ]
Eade, Thomas [4 ]
Dogan, Nesrin [1 ]
Stoyanova, Radka [2 ]
Abramowitz, Matthew [2 ]
机构：
[1] Univ Miami, Coral Gables, FL 33124 USA
[2] Univ Miami, Sylvester Comprehens Canc Ctr, Dept Radiat Oncol, Coral Gables, FL 33124 USA
[3] Univ Turin, Oncol 4Dept, Radiat Oncol, Turin, Italy
[4] Royal North Shore Hosp, Dept Radiat Oncol, St Leonards, NSW, Australia
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2020年 / 108卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
OA46
引用
收藏
页码：E21 / E21
页数：1
相关论文
共 50 条
  • [1] Early Toxicity and Patient Reported Outcomes from a Radiation Hypofractionation Randomized Trial of Extended vs Accelerated Therapy for Prostate Cancer (HEAT)
    Abramowitz, M. C.
    Kwon, D.
    Freeman, D. E.
    Dogan, N.
    Eade, T.
    Punnen, S.
    Dal Pra, A.
    Kneebone, A.
    Stoyanova, R.
    Pollack, A.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : E98 - E99
  • [2] Late Toxicity of Prostate Ultrahypofractionated Radiation Therapy Compared With Moderate Hypofractionation in a Randomized Trial
    Alexander, Abraham
    Gagne, Isabelle
    Bahl, Gaurav
    Kim, David
    Mestrovic, Ante
    Ye, Allison
    Kwan, Winkle
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 119 (01): : 110 - 118
  • [3] Patient-reported outcomes from the phase III prostate HYPRO trial: urinary toxicity
    Wortel, R. C.
    Incrocci, L.
    Pos, F. J.
    Smeenk, R. J.
    Krol, A. D. G.
    Aluwini, S.
    Witte, M. G.
    Heijmen, B. J. M.
    Heemsbergen, W. D.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2017, 123 : S295 - S297
  • [4] Stereotactic ultrahypofractionated MR-guided radiotherapy for localized prostate cancer - Acute toxicity and patient-reported outcomes in the prospective, multicenter SMILE phase II trial
    Fink, C. A.
    Ristau, J.
    Buchele, C.
    Klueter, S.
    Liermann, J.
    Hoegen-Sassmannshausen, P.
    Sandrini, E.
    Lentz-Hommertgen, A.
    Baumann, L.
    Andratschke, N.
    Baumgartl, M.
    Li, M.
    Reiner, M.
    Corradini, S.
    Hoerner-Rieber, J. Ho
    Bonekamp, D.
    Schlemmer, H. -P.
    Belka, C.
    Guckenberger, M.
    Debus, J.
    Koerber, S. A.
    [J]. CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY, 2024, 46
  • [5] Long-term Patient Reported Outcomes From a Phase 3 Randomized Prospective Trial of Conventional Versus Hypofractionated IMRT Radiation Therapy for Localized Prostate Cancer
    Shaikh, T.
    Li, T.
    Johnson, M. E.
    Wang, L.
    Hallman, M. A.
    Greenberg, R. E.
    Price, R. A., Jr.
    Uzzo, R.
    Ma, C. M. C.
    Chen, D.
    Pollack, A.
    Horwitz, E. M.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : S34 - S35
  • [6] Long-Term Patient-Reported Outcomes From a Phase 3 Randomized Prospective Trial of Conventional Versus Hypofractionated Radiation Therapy for Localized Prostate Cancer
    Shaikh, Talha
    Li, Tianyu
    Handorf, Elizabeth A.
    Johnson, Matthew E.
    Wang, Lora S.
    Hallman, Mark A.
    Greenberg, Richard E.
    Price, Robert A., Jr.
    Uzzo, Robert G.
    Ma, Charlie
    Chen, David
    Geynisman, Daniel M.
    Pollack, Alan
    Horwitz, Eric M.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 97 (04): : 722 - 731
  • [7] Patient-Reported Outcomes From a Phase 3 Randomized Controlled Trial Exploring Optimal Sequencing of Short-Term Androgen Deprivation Therapy With Prostate Radiation Therapy in Localized Prostate Cancer
    Roy, Soumyajit
    Grimes, Scott
    Morgan, Scott Carlyle
    Eapen, Libni
    Malone, Julia
    Craig, Julia
    Spratt, Daniel Eidelberg
    Malone, Shawn
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 110 (04): : 1101 - 1113
  • [8] Toxicity and Biochemical Outcomes of Dose-Intensified Postoperative Radiation Therapy for Prostate Cancer: Results of a Randomized Phase III Trial
    Qi, Xin
    Li, Hong-Zhen
    Gao, Xian-Shu
    Qin, Shang-Bin
    Zhang, Min
    Li, Xiao-Mei
    Li, Xiao-Ying
    Ma, Ming-Wei
    Bai, Yun
    Li, Xue-Ying
    Wang, Dian
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 106 (02): : 282 - 290
  • [9] Patient-Reported Financial Toxicity Following Definitive Radiation Therapy for Localized Prostate Cancer
    Gorovets, D.
    Tin, A.
    Vickers, A. J.
    Zelefsky, M. J.
    Ehdaie, B.
    Imber, B. S.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (03): : E274 - E274
  • [10] Ultrahypofractionated versus hypofractionated and conventionally fractionated radiation therapy for localized prostate cancer: A systematic review and meta-analysis of phase III randomized trials
    Lehrer, Eric J.
    Kishan, Amar U.
    Yu, James B.
    Trifiletti, Daniel M.
    Showalter, Timothy N.
    Ellis, Rodney
    Zaorsky, Nicholas G.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2020, 148 : 235 - 242
12345